Treatment Options for Niemann-Pick Type C
Por um escritor misterioso
Descrição
Elizabeth Berry-Kravis, MD, PhD, co-director of the Molecular Diagnostics Section of the Genetic Laboratory at Rush Medical College in Chicago, describes dif
Valley family fights for drug to save sick child
Treating Niemann-Pick Disease Type C
Niemann–Pick Disease Type C
From genes to hope
Frontiers Adult-Onset Niemann–Pick Disease Type C: Rapid Treatment Initiation Advised but Early Diagnosis Remains Difficult
Protocol for initiation of miglustat treatment in NP-C. Reproduced with
NPC PFDD - Overview of Niemann-Pick Type C Disease and Current Treatments
Niemann-Pick disease A or B in four pediatric patients and SMPD1 mutation carrier frequency in the Mexican population
Correlation of age of onset and clinical severity in Niemann–Pick disease type C1 with lysosomal abnormalities and gene expression
Niemann-Pick type C: contemporary diagnosis and treatment of a classical disorder
IJMS, Free Full-Text
Niemann–Pick type C disease: cellular pathology and pharmacotherapy - Wheeler - 2020 - Journal of Neurochemistry - Wiley Online Library
Niemann-Pick Disease - Types, Causes, Symptoms, Diagnosis & Treatment
Niemann-Pick Disease Type C Treatment Market Size & Trends 2020- expected to reach US$ 378.8 Million With CAGR of 42.3% by 2027, Orphazyme A/S, Cyclo Therapeutics, Inc., and Johnson & Johnson
de
por adulto (o preço varia de acordo com o tamanho do grupo)
:strip_icc()/i.s3.glbimg.com/v1/AUTH_08fbf48bc0524877943fe86e43087e7a/internal_photos/bs/2021/a/8/MlMDUfS9eDXUnFXybKYA/2012-10-31-sonyrevisaopsone.jpg)
